Adex 1
Nakon Medical1 mg per tablet
$45.00
In stock
Photograph of the product as supplied
Femara 2.5 Mg
Made by Novartis
No reviews yet
$55.00
In stock
Femara 2.5 Mg by Novartis. Oral tablet, listed under Letrozole (Femara), in Post Cycle.
- CompoundFemara 2.5 Mg
- Concentration2.5 mg
- ProtocolFor research purposes only.
1
- Tracked, unmarked
- 30-day returns
About this compound
Letrozole, sold as Femara, an aromatase inhibitor prescribed for breast cancer.
Femara 2.5 Mg is a Novartis product in the Post Cycle range, grouped with the other Letrozole (Femara) listings. What is shown here comes from the product as photographed and from its listing name: the strength of 2.5 mg is transcribed from the name and should be confirmed against the label. This catalogue adds no claims of its own about purity, effect or dosing.
Compare all 15 Letrozole (Femara) listings by strength and price
What it is used for
- Listed under Letrozole (Femara), in Post Cycle
- Manufacturer: Novartis
- Strength as labelled: 2.5 mg
- Active compound: Letrozole
Directions
For research purposes only. Follow the directions on the manufacturer’s label; this listing adds no dosing guidance.
Ingredients
- Letrozole
Specification
| Strength | 2.5 mg |
|---|---|
| Form | Oral tablet |
| Group | Letrozole (Femara) |
| Manufacturer | Novartis |
| Compound | Letrozole |
Shipping
Ships within 24 hours in discreet packaging. Tracked delivery available.
Returns
Unopened, sealed products may be returned within 14 days.
Reviews
Nobody has reviewed this compound yet.
From the same bath
Other post cycle in the catalogue.
